Medical Book

See Also

Psychotherapy Web


Thursday 20th of November 2008

Human Growth Hormone > Nutropin > United States

Please select a HGH news story from the list below:

Business Wire - Introducing the Brand New Report on Business Strategies for Different Types of Biogenerics

Thursday 6th of December 2007

December 6, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76537) has announced the addition of new Decision Resources...

Business Wire - Ipsen: Somatuline® Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly

Friday 31st of August 2007

August 31, 2007 -- Somatuline([R]) Depot Becomes the First Product Originating from Ipsen's R&D to Be Approved by the FDA and Marketed Globally(1) PARIS --...

Business Wire - Ipsen's First Half 2007 Results and Financial Objectives for the Full Year 2007

Wednesday 29th of August 2007

August 29, 2007 -- * Increased effort in Research & Development * Results in line with management expectations: full year 2007 operating margin guidance confirmed...

Business Wire - IPSEN: Increlex® Receives Marketing Authorisation in the European Union

Thursday 9th of August 2007

August 9, 2007 -- PARIS -- Regulatory News: Increlex([R]) is the First Recombinant Human Insulin-Like Growth Factor-1 Therapy Approved in Europe for Severe Primary...

Business Wire - Tercica Reports Second Quarter 2007 Financial Results

Thursday 2nd of August 2007

August 2, 2007 -- --Company Increases Increlex 2007 Revenue Guidance-- BRISBANE, Calif. -- Tercica, Inc. (Nasdaq:TRCA) today announced financial results for the...

Business Wire - Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization

Tuesday 10th of July 2007

July 10, 2007 -- Combination Products for the Potential Treatment of Short Stature and Adult Growth Hormone Deficiency Tercica May Receive up to $53 Million in...

Business Wire - Ipsen: Increlex® Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency

Friday 25th of May 2007

May 25, 2007 -- PARIS -- Regulatory News: Upon marketing authorization, Increlex([R] )will be commercialized in the European Union by Ipsen, Tercica's partner...

Business Wire - Ipsen's Full Year 2006 Results

Monday 19th of March 2007

March 19, 2007 -- * Recurring Operating Margin((2)) above Objectives: 23.7% of Net Sales * Strong Increase in Recurring Consolidated Profit((2)): +15.6% * All Time...

Business Wire - Ipsen and Tercica Complete Worldwide Strategic Collaboration Agreement in Endocrinology

Monday 16th of October 2006

October 16, 2006 -- PARIS & BRISBANE, Calif. -- Ipsen (Euronext:IPN) and Tercica, Inc. (Nasdaq:TRCA) today announced the closing of their worldwide strategic...

Cities

Province/State

Countries


About

Our goal is to spread human growth hormone information in the form of general information and useful HGH articles from a wide variety of print publications.


Add a Bookmark

If we've proved to be a useful resource why not now?


designed: expert answers